Swiss Biotech Stock News

Alcon (SWX:ALC) shares have lost ground over the past month, with the stock declining about 2%. Investors may be wondering whether this pullback creates an opportunity, especially given the company's steady revenue and net income growth. See our latest analysis for Alcon. Alcon’s recent dip extends a much steeper slide, as the stock is down over 22% year-to-date and the 1-year total shareholder return is off by 26.1%. This pullback marks a clear loss of momentum compared to its steady...

Barry Callebaut (SWX:BARN) reported earnings that underscore a mixed picture. Revenue is projected to decline at 0.7% per year over the next three years, while current net profit margins have slipped to 1.3% from 1.8% last year. Over the last five years, the company’s earnings have fallen by 12.5% annually, and this past year included a CHF 79.6 million one-off loss. Despite the lackluster historical trend, future prospects look brighter, with analysts forecasting annual earnings growth of...

UBS Group (SWX:UBSG) shares have shown mixed signals over the past month, dipping slightly despite a solid year-to-date gain. Investors are closely watching recent trends to gauge where the stock could head next. See our latest analysis for UBS Group. UBS Group's recent 4.6% dip in 1-month share price return has not erased the tailwind from a strong year-to-date gain. Long-term investors have enjoyed a robust 190.7% total shareholder return over five years. Momentum appears to be shifting...

You may think that with a price-to-sales (or "P/S") ratio of 0.3x ams-OSRAM AG ( VTX:AMS ) is a stock worth checking...

Wondering whether ABB might be a bargain or just riding the wave? Here is a breakdown of what the numbers and recent events could mean for anyone curious about the stock’s real value. The stock has seen a strong run, climbing 18.3% year to date and up 177.8% over five years. There has been a slight dip of -2.5% in the past week. Recent news around ABB’s expansion into electrification solutions and investments in automation have powered investor optimism. At the same time, shifting...

As the European markets experience mixed performances, with the pan-European STOXX Europe 600 Index recently pulling back after reaching fresh highs, investor attention is increasingly turning towards growth companies with high insider ownership. In this environment, stocks that combine robust growth potential and significant insider investment can offer unique insights into confidence levels within a company, making them noteworthy for investors seeking opportunities in a fluctuating market...

With a median price-to-sales (or "P/S") ratio of close to 1.7x in the Electronic industry in Switzerland, you could be...

Sika (SWX:SIKA) has just rolled out the Sika Carbon Compass, an automated tool designed to calculate product carbon footprints. This move aligns with the company’s focus on sustainability and new environmental standards. See our latest analysis for Sika. Even as Sika introduces forward-looking sustainability initiatives, the stock’s momentum has faded, with a 1-year total shareholder return of -36.5%. Recent earnings revealed both sales and profit slid compared to last year, and cautious new...

Ever find yourself wondering if Roche Holding is a hidden gem or just another pharmaceutical heavyweight trading at a premium? You are not alone. Today we are cutting through the noise to tackle exactly how to think about its value. Despite a recent 3.0% dip over the last week and a 9.5% slide in the past month, Roche Holding is still up 1.1% since the start of the year. This suggests the market is still weighing its long-term prospects against short-term bumps. Recent announcements about...

There wouldn't be many who think Clariant AG's ( VTX:CLN ) price-to-earnings (or "P/E") ratio of 20.4x is worth a...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

With its stock down 20% over the past three months, it is easy to disregard Ypsomed Holding (VTX:YPSN). But if you pay...

Those following along with Amrize AG ( VTX:AMRZ ) will no doubt be intrigued by the recent purchase of shares by Jan...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Chocoladefabriken Lindt & Sprüngli fair value estimate is...

Key Insights Significant control over Vetropack Holding by retail investors implies that the general public has more...

Bell Food Group (VTX:BELL) has had a rough three months with its share price down 11%. However, stock prices are...

DKSH Holding's (VTX:DKSH) stock up by 3.3% over the past month. As most would know, long-term fundamentals have a...

Smartee Denti-Technology and Straumann Group recently announced a partnership to jointly develop next-generation orthodontics platforms, co-innovate clear aligner technologies, and involve a single-digit equity investment by Smartee. This collaboration combines Smartee's manufacturing and technology expertise in China's clear aligner market with Straumann's global brand and distribution network, aiming to meet rising global demand for high-quality orthodontic solutions more...

Earlier this month, the Canadian Space Agency awarded ABB a contract to develop the conceptual design of the Thin Ice Clouds and Far InfraRed Emissions (TICFIRE) instrument, a critical part of Canada's High-altitude Aerosols, Water Vapour and Clouds (HAWC) satellite mission for climate monitoring. This initiative highlights the importance of advanced infrared sensing technologies in addressing pressing climate science questions that traditional observation methods cannot resolve from Earth’s...

Amrize (SWX:AMRZ) reported its net profit margin at 10%, edging higher than last year’s 9.5%, a clear sign of better profitability. Over the past five years, the company’s earnings have grown at an annual rate of 8.1%, but the latest twelve months saw a slower 4.9% rise. With analysts forecasting earnings growth of 15.4% per year, comfortably ahead of both the Swiss market and industry peers, investors are now weighing the implications of robust growth expectations against a share price that...

Novartis (SWX:NOVN) posted strong earnings for the period, with profits rising 22.4% year over year, well above its 5-year average annual growth of just 0.09%. Net profit margin climbed to 25.5% from 23.6% a year ago, signaling improved profitability. While revenue growth is forecast at 3.4% per year, trailing the Swiss market average of 4%, ongoing momentum and a current share price of CHF98.5, which is below estimated fair value, give investors plenty to analyze as they look ahead. See our...

Harrington Process Solutions recently announced an expansion of its partnership with Georg Fischer, granting Harrington full-line access to Georg Fischer's flow control products for corrosive waste and high purity applications across the United States. This expanded collaboration strengthens both companies' capabilities and market reach, particularly in mission-critical industries such as data centers, life sciences, and biopharmaceuticals. We'll examine how broader national distribution of...

Sandoz Group AG recently presented at CPhI Worldwide Frankfurt 2025, highlighting new developments with key presentations from its Chief Commercial Officer and Chief Scientific Officer at Messe Frankfurt in Germany. For the first nine months of 2025, Sandoz reported a 5% net sales increase at constant currencies, with biosimilars making up over 30% of total net sales for the first time and an upgraded full-year margin outlook reflecting successful infrastructure expansion. We will consider...

Sonova Holding (SWX:SOON) just introduced its Infinio Ultra product lineup, expanding on last year’s Sphere Infinio release. The latest launch features the DEEPSONIC AI chip, which is designed to deliver clearer speech in noisy environments. See our latest analysis for Sonova Holding. Despite Sonova’s leadership in hearing tech and its bold move with the Infinio Ultra launch, the company’s share price has felt the pressure this year. The stock recently closed at CHF 223.10 and delivered a...